Celadon Pharmaceuticals Plc (AIM:CEL)
London
· Delayed Price · Currency is GBP · Price in GBX 8.00
+0.50 (6.67%)
Mar 28, 2025, 4:29 PM GMT+1
Celadon Pharmaceuticals Revenue
Celadon Pharmaceuticals had revenue of 63.00K GBP in the half year ending June 30, 2024, with 472.73% growth. This brings the company's revenue in the last twelve months to 130.00K, up 519.05% year-over-year. In the year 2023, Celadon Pharmaceuticals had annual revenue of 75.00K with 212.50% growth.
Revenue (ttm)
130.00K
Revenue Growth
+519.05%
P/S Ratio
39.01
Revenue / Employee
4.81K
Employees
27
Market Cap
5.51M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
Celadon Pharmaceuticals News
- 2 days ago - AIM Market Roundup:Premier African Minerals, UK Oil & Gas, Naked Wines - The Armchair Trader
- 4 weeks ago - AIM Market Roundup: Trellus Health, Celadon Pharma, Nahl - The Armchair Trader